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responsibility of XAbstract The electrochemical oxidation behavior and voltammetric assay of gemiﬂoxacin were
investigated using differential-pulse and cyclic voltammetry on a screen-printed carbon electrode.
The effects of pH, scan rates, and concentration of the drug on the anodic peak current were
studied. Voltammograms of gemiﬂoxacin in Tris–HCl buffer (pH 7.0) exhibited a well-deﬁned
single oxidation peak. A differential-pulse voltammetric procedure for the quantitation of
gemiﬂoxacin has been developed and suitably validated with respect to linearity, limits of detection
and quantiﬁcation, accuracy, precision, speciﬁcity, and robustness. The calibration was linear from
0.5 to 10.0 mM, and the limits of detection and quantiﬁcation were 0.15 and 5.0 mM. Recoveries
ranging from 96.26% to 103.64% were obtained. The method was successfully applied to the
determination of gemiﬂoxacin in pharmaceutical tablets without any pre-treatment. Excipients
present in the tablets did not interfere in the assay.
& 2013 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Fluoroquinolones have emerged as one of the most important
classes of antibiotics in the past decade [1–3]. Gemiﬂoxacinersity. Production and hosting by E
.005
40 3867;
(A.-E. Radi).
i’an Jiaotong University.(GFX), 7-[(4Z)-3-(aminomethyl)4-methoxyimino-pyrrolidin-1-yl]-
1-cyclopropyl-6-ﬂuoro4-oxo-1,8-naphthyridine-3-carboxylic acid
methanesulfonate (Scheme 1), is a new ﬂuoroquinolone antibac-
terial compound with enhanced afﬁnity for bacterial topoisome-
rase IV, with a broad spectrum of activity against Gram-positive
and Gram-negative bacteria, and has been developed to treat
pneumonia or bronchitis [4–6]. GFX is being approved by the US
Food and Drug Administration for treatment of the upper
respiratory tract infections [7].
Literature revealed that few analytical methods have been
reported for the estimation of GFX. They include high-
performance liquid chromatography–tandem mass spectrome-
try (LC-MS-MS) [8], microchip electrophoresis [9,10], chiral
high-performance liquid chromatography [11–13] and chirallsevier B.V. All rights reserved.
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Scheme 1 Chemical structure of gemiﬂoxacin.
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methods have been reported for GFX determination [15–23]. A
ﬂuorometric method [24] for determination of GFX in plasma has
been described. The determination of GFX is not yet described in
any pharmacopoeias. Therefore, a simple and accurate method is
required for its determination in pharmaceutical formulations.
The electroanalytical techniques have proven to be useful
for selective and sensitive quantitation of many drugs owing to
their excellent speciﬁcity, sensitivity, speed of analysis and
relative low cost, and, therefore, have been used to determine
the active pharmaceutical ingredients in bulk, dosage forms,
and biological matrices [25–27]. The electrochemical behavior
of the drugs can also give insights into their metabolic
pathway or their in vivo redox processes or pharmacological
activities [28]. Voltammetric determination based on the
electrochemical reduction of GFX in solubilized systems at
multi-walled carbon nanotubes modiﬁed screen-printed car-
bon electrode has been reported [29].
The development of screen-printing techniques for fabrication
of versatile, inexpensive and disposable electrodes has been a
boon to electroanalytical chemistry for various applications.
Screen-printed electrodes are planar devices, based on different
layers of inks printed on a plastic, glass or ceramic substrate.
Many ink-type substrates have been used for sensor construc-
tion, where the most successful ones have included carbon and
the noble metals as Au, Pt, Ag, etc. The main advantage of this
kind of electrode system lies in its modest cost, potential
portability, simplicity of operation, reliability, and the small
instrumental arrangement containing the working electrode,
auxiliary and reference electrodes. Therefore, the effective per-
formance of screen-printed electrodes has gained consideration in
environmental, biomedical and occupational hygiene monitoring
and all the major ﬁelds of analytical chemistry [30,31].
In the present study, the voltammetric behavior of GFX on
screen-printed carbon electrodes using cyclic and differential-
pulse voltammetry was reported. The study also described the
optimization, validation and application of screen-printed
carbon electrodes for determination of GFX in pharmaceu-
tical tablet formulation.2. Experimental
2.1. Apparatus
Voltammetric measurements were carried out using CHI610C
Electrochemical Analyzer controlled by CHI Version 9.09software (CH Instruments, USA). A three-electrode conﬁg-
uration was composed of a working screen-printed carbon
electrode (3.1 mm diameter), printed from a carbon-based ink;
a silver–silver chloride pseudo-reference electrode made from a
silver-based ink; and the auxiliary electrode from a carbon ink.
All pH-metric measurements were made on a CG 808 (Schott
Gerate, Germany) digital pH-meter with glass combination
electrode, which was previously standardized with buffers of
known pHs. The UV spectra were performed by a Perkin-
Elmer UV–vis double beam spectrophotometer equipped with
a PC for data processing UV WinLab-ver 2.80.03 (Perkin-
Elmer, USA). The spectra were recorded over the wavelength
range from 200 to 350 nm at a scan speed of 240 nm/min.
Aquartz cell with a 1.0 cm path length was used. Fluorescence
spectra were taken on a ﬂuorospectrophotometer Model: 6285
(Jenway, UK). The spectra were recorded over the wavelength
range from 200 to 650 nm at a scan speed of 1000 nm/min.
2.2. Reagents and solutions
All chemicals were of analytical reagent grade and used without
further puriﬁcation. Tris–HCl buffer solutions (0.1 M) were
used as the supporting electrolytes in all experiments. GFX
standard and Factives tablets, each containing GFX mesylate
equivalent to 320 mg of GFX, were supplied by LG Life
Sciences, Ltd. (Seoul, South Korea). Milli-Q water was used
for preparing all solutions used in this study. Stock solutions
were protected from light and stored at 4 1C.
2.3. Procedure
Aliquots of 200 mL of the supporting electrolyte solution and
sample solution containing increased concentration of GFX were
dropped onto the surface of the sensor, and the voltammograms
initiated in the positive direction were recorded directly without
any accumulation time.
2.3.1. Procedure for Factives tablets
The proposed method was tested to determine GFX in
pharmaceutical formulation, commercialized tablets Factives,
using the following procedure: ﬁve tablets were weighed and
powdered. The average mass per tablet was determined.
A quantity of the powder, equivalent to 320 mg of GFX, was
transferred accurately to 1.0 mL of 0.1 M Tris–HCl (pH 7.0)
and dissolved ultrasonic bath for 5 min. An aliquot of the clear
supernatant liquor was then transferred to a volumetric ﬂask
containing buffer working solution to yield a ﬁnal concentra-
tion of 10.0 mM GFX. The DP voltammograms were then
recorded; the content of the drug in tablets was determined by
the standard addition method. The same solutions were also
analyzed by the spectral reference methods. All measurements
were carried out at ambient temperature.3. Results and discussions
The pH of the solution had signiﬁcant effects on the anodic
peak current response and peak potential of GFX. The effect
of pH on the anodic oxidation of GFX was investigated over a
pH range between 2.0 and 11.0. Exemplary differential-pulse
voltammograms of 1.0 mM GFX recorded at screen-printed
-0.2 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4
0
1
2
3
4
pH4.0
pH 5.0
pH 6.0
pH 10
C
ur
re
nt
 (μ
A
)
E/V vs. Ag-AgCl ref. electrode
pH 7.0
Fig. 1 Differential pulse voltammograms for 1.0 mM gemiﬂox-
acin in Tris buffer solutions of different pH values, at screen-
printed carbon electrode. Scan rate, 10 mV/s; pulse amplitude,
50 mV and pulse width, 30 ms.
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Fig. 2 Cyclic voltammograms for 50.0 mM gemiﬂoxacin in 0.1 M
Tris–HCl pH 7.0 buffer solution at screen-printed carbon elec-
trode. Scan rate¼100 mV/s.
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Fig. 3 Differential pulse voltammograms for 1.0 mM gemiﬂox-
acin in 0.1 M Tris–HCl pH 7.0 buffer solution at screen-printed
carbon electrode. Scan rate, 10 mV/s; pulse amplitude, 50 mV and
pulse width, 30 ms. Inset is the calibration plot.
A.-E. Radi et al.134carbon electrodes in 0.1 M Tris–HCl working solution at
different pH values are presented in Fig. 1. In acidic
(pH¼2.0–4.0) or alkaline media (pH¼8.0–11.0) no signal of
the analyte was observed. In contrast, in the pH range 5.0–7.0,
the voltammetric oxidation response of GFX was well-deﬁned.
Oxidation peak shifted to less positive potentials with the
increase of the pH, indicating that protons participated in the
current-limiting electrode process. Since the best-deﬁned and
maximum peak was obtained at pH 7.0, this pH value was
maintained during further optimization and determination of
the analyte.
Typical cyclic voltammogram obtained for the oxidation of
50.0 mM GFX in 0.1 M Tris–HCl buffer solution (pH 7.0) on
SPCE is shown in Fig. 2. The curve obtained for oxidation of
GFX presents one anodic peak at 0.640 V vs. Ag–AgCl
reference electrode. The fact that no peak was observed in
the reverse scan suggests that the oxidation process is an
irreversible one. The dependence of the peak intensity of the
oxidation process at the SPE on the scan rate (n) was
examined. A linear plot of i vs. n1/2 should be obtained when
the electrode process is diffusion-controlled, whereas the
adsorption-controlled process should result in linear plot i
vs. n. When the potential was scanned at increasing rates from
5 to 250 mV/s, under the same experimental conditions, a
linear relationship was observed between the peak intensity i
and the scan rate n:i (mA)¼0.012þ0.031n (mV/s), suggesting
that the GFX oxidation at the electrode surface is an
adsorption-controlled process [32]. GFX showed a positive
shift in the peak potential, a further indication of the
irreversibility of GFX electrochemical oxidation process.
The instrumental variables for the quantitative determina-
tion of GFX were examined and the differential-pulse voltam-
metric method was found to have a higher sensitivity in
comparison to other electroanalytical techniques. The increase
of GFX concentration in 0.1 M Tris–HCl pH 7.0 was followed
by the proportional increase of DPV peak height (pulse
amplitude 50 mV, pulse width 50 ms and scan rate 10 mV/s)
as shown in Fig. 3. A linear dependence was observed within
the GFX concentration range: 0.5–10.0 mM GFX. It wasdescribed by the equation: i(mA)¼0.009þ0.15 C (mM);
r¼0.993. Each point of the calibration curve corresponded
to the mean value obtained from three measurements. Devia-
tion from linearity appeared for more concentrated solutions
due to the adsorption of GFX or its oxidation product.
Extended linearity (linearity at higher concentration) experi-
ment performed showed that the signiﬁcant dilution of the
sample before measurement could also play an important role
in improving linear behavior. The standard deviations for the
intercept and the slope of the calibration line were 0.65 mA and
0.15 mA/mM, respectively. The detection limit of the procedure
(LOD¼3Sy/x/b [33], where Sy/x is the standard deviation of y-
residuals and b is the slope of the calibration plot), was
calculated to be 0.15 mM and the limit of quantitation
(LOQ¼3Sy/x/b) was 0.050 mM.
Three different concentrations of GFX (0.50, 0.75 and
1.00 mM) were analyzed over six independent series on the same
day (intra-day precision) and six consecutive days (inter-day
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Fig. 5 The excitation and emission spectra of gemiﬂoxacin (0.5,
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were 1.84 and 3.44 for GFX, respectively, suggesting that the
intermediate precision of the method was satisfactory. Robust-
ness tests were performed to investigate the reliability of results
when the experimental parameters including ionic strength of
supporting electrolyte, pH and instrumental DP pulse para-
meters were slightly changed deliberately. Test solution of
10.0 mM GFX standard solution was prepared and analyzed
under each condition, and assay of GFX was determined. No
signiﬁcant difference was found between the results, indicating
the robustness of the method.
For the speciﬁcity test, the response of the standard
solution (1.00 mM) with or without different amounts of
various excipients was compared. No signiﬁcant change was
observed. Therefore, excipients as majority compound in
commercial tablet samples did not interfere in the quantitation
of GFX. The accuracy of the proposed method was performed
by spiking the synthetic mixture with known amounts of GFX
(0.50, 0.75 and 1.00 mM). Recoveries ranging from 96.2% to
103.64% for the drug were found.
The stability of the electrochemical response is one of the
most critical factors for assessing the possibilities of a screen-
printed electrode to be applied in control process and routine
monitoring. Although screen-printed electrodes are commer-
cialized as disposable electrochemical sensors, the DP voltam-
mograms recorded successively for GFX in 0.1 M Tris–HCl
pH 7.0 buffer working solution at screen-printed electrodes
showed negligible changes for the anodic peak. This assay
demonstrates that there is no memory effect during the
analysis or electrode poisoning and that the potential scan
initiated in the positive direction in a blank supporting
electrolyte is enough for cleaning the electrode surface. The
relative standard deviation at 1.0 mM was around 4.40% with
ﬁve different electrodes and around 3.64% using the same
electrode (ﬁve repetitions).
Spectrophotometric and spectroﬂuorometric methods were
developed for determination of GFX. Fig. 4 shows the UV–vis
spectrum of GFX and the calibration plot obtained between
the concentration and the absorbance values. The method was
linear over the concentration range of 5.0–100.0 mM, and the
RSD value at 50.0 mMGFX was 3.53%. The limit of detection220 240 260 280 300 320 340 360 380 400
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Fig. 4 UV–vis spectra of gemiﬂoxacin at different concentrations
from 5.0 to 100 mM in 0.1 M Tris–HCl pH 7.0 buffer solution.
Inset: calibration plot of gemiﬂoxacin at lmax¼545.61 nm.and the limit of quantitation were 1.50 and 5.00 mM, respec-
tively. A method based on direct measurement of GFX
ﬂuorescence intensity was also proposed. Fig. 5 shows the
excitation and emission spectra of GFX and the calibration
plot obtained. The method was linear over the concentration
range of 0.5–80.0 mM, and the RSD value at 25.0 mM GFX
was 4.00%. The limit of detection and the limit of quantitation
were 0.20 and 0.65 mM, respectively.
The optimized electroanalytical method was successfully
applied for determination of GFX in pharmaceutical formula-
tion commercialized as Factives using the standard addition
method. No tedious extraction or ﬁltration procedures have
been applied during sample preparation and only dilution of
aliquot from the supernatant layer with the supporting
electrolyte (0.1 M Tris–HCl pH 7.0) is required before mea-
surement. Recoveries of 108.8873.64% of GFX were
obtained for the pharmaceutical formulation samples (n¼5).
Table 1 gives the results obtained for the spectral methods and
the DPV method, as well as the label values of the samples
analyzed. The statistical calculations for the assay results
suggested good precision for the DPV method. The results10.0, 40.0, and 50.0 mM). Inset: calibration plot of gemiﬂoxacin at
lmax¼545.61 nm.
Table 1 Application of the three different methods for
the determination of GFX in Factives tablets.
Factives
tablets
(320 mg
gemiﬂoxacin/
tablet)
DPV
method
UV–vis
method
Fluorimetric
method
Mean7SD 322.81711.67 318.39711.32 320.20712.82
t 0.61; 0.36
(2.31)
F 1.06; 0.83
(9.605)
Each result is the average of ﬁve separate assays.
Values between brackets are the tabulated t and F values at
p¼0.05.
A.-E. Radi et al.136obtained were also compared by applying the t and F tests.[33]
The calculated t and F values do not exceed the theoretical
values at 95% conﬁdence level. Therefore, there is no signiﬁcant
difference between the three methods with respect to the mean
values and the standard deviations; therefore, the three methods
are equally applicable.4. Conclusion
This is the ﬁrst use of screen-printed carbon electrodes for the
anodic voltammetric determination of GFX. The advantages
of screen-printed carbon electrodes include low cost, potential
for miniaturization, facility of automation, and easy construc-
tion of simple and portable equipment. The good analytical
performance of the proposed electroanalytical method such as
precision, speciﬁcity, accuracy, robustness, good recoveries
and minimal sample preparation for determination of GFX in
tablet formulations has been demonstrated. The results are in
agreement with those found with the spectral alternative
methods. Therefore, the DPV method is very suitable for
routine determination of GFX.
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